首页> 外文期刊>Medicine. >The Efficacy and Toxicity of Paclitaxel Plus S-1 Compared With Paclitaxel Plus 5-Fu for Advanced Gastric Cancer A PRISMA Systematic Review and Meta-analysis of Randomized Controlled Trials
【24h】

The Efficacy and Toxicity of Paclitaxel Plus S-1 Compared With Paclitaxel Plus 5-Fu for Advanced Gastric Cancer A PRISMA Systematic Review and Meta-analysis of Randomized Controlled Trials

机译:与紫杉醇加上S-1的疗效和毒性与紫杉醇加5-FU,用于晚期胃癌的普遍系统综述和随机对照试验的荟萃分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The standard treatment for patients with advanced gastric cancer (AGC) is still a matter of debate. The chemotherapy regimen of paclitaxel (PTX) combined with S-1 has been used to treat AGC or metastatic gastric cancer.
机译:晚期胃癌(AGC)患者的标准治疗仍然是辩论问题。 紫杉醇(PTX)的化疗方案与S-1合并已用于治疗AGC或转移性胃癌。

著录项

  • 来源
    《Medicine.》 |2014年第25期|共7页
  • 作者单位

    China Med Univ Hosp 1 Dept Surg Oncol &

    Gen Surg Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Hosp 1 Dept Surg Oncol &

    Gen Surg Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Hosp 1 Dept Surg Oncol &

    Gen Surg Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Hosp 1 Dept Surg Oncol &

    Gen Surg Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Hosp 1 Dept Surg Oncol &

    Gen Surg Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Pathophysiol Sch Basic Med Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Hosp 1 Dept Surg Oncol &

    Gen Surg Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Hosp 1 Dept Surg Oncol &

    Gen Surg Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Hosp 1 Dept Surg Oncol &

    Gen Surg Shenyang 110001 Liaoning Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号